Rekvina Labs Ltd Financials
Company Logo

Rekvina Labs Ltd Financial Statement

Rekvina Labs Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2025
RevenueTBA
Operating Expense0.04
Net Profit-0.04
Net Profit MarginTBA
Earning Per Share0.05
EBIDTA-0.04
Effective Tax RateTBA

Rekvina Labs Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue AnnualTBA
Operating Expenses Annual0.02
Operating Profit Annual-0.02
Interest AnnualTBA
DepreciationTBA
Net Profit Annual-0.02
Tax AnnualTBA

Rekvina Labs Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning0.01
Cash Flow from OperationsTBA
Cash Flow from InvestingTBA
Cash Flow from FinancingTBA
Cash Flow at the End0.01

Rekvina Labs Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)TBA
PBIT Margin (%)TBA
PBT Margin (%)TBA
Net PROFIT Margin (%)TBA
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)TBA
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)TBA

Rekvina Labs Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual0.15
Total Current Assets Annual0.01
Non Current Assets Annual0.19
Total Shareholders Funds Annual-0.00
Total Assets Annual0.20

Rekvina Labs Ltd Earning Calls

No Data Availabe

FAQS on Rekvina Labs Ltd Financials

As of Aug 29, 2025, Rekvina Labs Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.

Yes, Rekvina Labs Ltd is with a debt-to-equity ratio of -0.75.

In FY 2024 , Rekvina Labs Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.

Rekvina Labs Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and NaN% annually, respectively..

Rekvina Labs Ltd's current PE ratio is .

Rekvina Labs Ltd's ROCE averaged 37.7% from the FY ending March 2023 to 2025, with a median of -2.3%. It peaked at 160.5% in March 2025, reflecting strong capital efficiency over the period..

Rekvina Labs Ltd's latest EBIT is Rs. -0.14 Cr, surpassing the average EBIT of Rs. -0.05 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions